RCKT
Rocket Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -7.7% ·
share flow -30.0% ·
net new positions -8.3%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | -1 | 55.09M | $188.40M | +4 | −5 |
| Q1 2026 | 83 | +2 | 57.14M | $204.44M | +8 | −6 |
| Q4 2025 | 81 | +2 | 51.01M | $179.05M | +2 | — |
| Q3 2025 | 15 | 0 | 38.20M | $124.54M | — | — |
| Q2 2025 | 12 | -1 | 25.35M | $62.12M | +2 | −3 |
| Q1 2025 | 10 | -1 | 24.61M | $164.16M | +1 | −2 |
| Q4 2024 | 11 | 0 | 29.17M | $366.63M | +1 | −1 |
| Q3 2024 | 10 | 0 | 19.68M | $363.43M | +2 | −2 |
| Q2 2024 | 10 | — | 17.23M | $370.95M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passive) | 7.43M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passive) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passive) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passive) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passive) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passive) | 6.12M | — | $15.00M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Millennium Management ✦ | 2.35M | +214.4% | $5.75M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Geode Capital Management ✦ (passive) | 2.03M | +1.9% | $4.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passive) | 2.03M | +1.9% | $4.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | State Street Global Advisors ✦ (passive) | 1.94M | -47.5% | $4.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | Two Sigma Investments ✦ | 1.73M | New | $4.23M | 0.0% | New | 1 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 1.10M | -63.9% | $2.70M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | T. Rowe Price ✦ | 1.10M | -63.9% | $2.70M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 992.83K | New | $2.43M | 0.0% | New | 1 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 992.83K | New | $2.43M | 0.0% | New | 1 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 777.67K | +375.3% | $1.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 777.67K | +375.3% | $1.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 777.67K | +375.3% | $1.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 777.67K | +375.3% | $1.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 35 | Renaissance Technologies ✦ | 461.37K | +36.3% | $1.13M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 266.05K | — | $651,819 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 266.05K | — | $651,819 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Citadel Advisors ✦ | 156.05K | -89.7% | $382,322 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Citadel Advisors ✦ | 156.05K | -89.7% | $382,322 | 0.0% | ▼ Trim | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Two Sigma Investments | $4.23M | 0.0% |
| D. E. Shaw & Co. | $2.43M | 0.0% |
| D. E. Shaw & Co. | $2.43M | 0.0% |
Exited
| Wellington Management | $84.22M | was 0.0% |
| Marshall Wace | $2.93M | was 0.0% |
| Norges Bank | $295,441 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 195 holders, 96.37M shares, $341.40M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 2.29K sh · $7,753
Officer · 631 sh · $2,133
Officer · 4.70K sh · $16,449
Officer · 36.66K sh · $128,266
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology